October 5, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative positron emission tomography (PET) radiopharmaceuticals, today announced results from a sub-group analysis from the Phase 3 LIGHTHOUSE trial (

October 5, 2023 — Researchers from Memorial Sloan Kettering Cancer Center (MSK) were recognized for their achievements at the 2023 meeting of ASTRO, the American Society for Therapeutic Radiology and Oncology. Teams reported new findings about radiation-induced secondary cancers, a new guidance system for radiation therapy, and the consequences of insurance denials, among other topics.

October 4, 2023 — Butterfly Network, Inc. a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, and 

October 4, 2023 — A new artificial intelligence (AI) model combines imaging information with clinical patient data to improve diagnostic performance on chest X-rays, according to a study published in Radiology, a journal of the Radiological Society of North America (

October 4, 2023 — An AI chest X-ray foundation model for disease detection demonstrated racial and sex-related bias leading to uneven performance across patient subgroups and may be unsafe for clinical applications, according to a study published today in 

October 4, 2023 — RaySearch Laboratories AB has announced its expanded collaboration with P-Cure, aiming at enhancing the workflow efficiency of P-Cure’s proton therapy system through integration with RaySearch’s systems RayStation and RayCare.

October 3, 2023 — Mevion Medical Systems, the leading global provider of compact proton therapy solutions, and RaySearch Laboratories AB, the market leader in software solutions for radiation oncology, are proud to announce their continued commitment to developing new proton therapy solutions.

October 3, 2023 — The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. 

October 3, 2023 — Medical device company GT Medical Technologies, Inc. announced interim findings of a multi-institutional study that demonstrates high local control for the treatment of recurrent brain metastases in patients. The findings add to the growing evidence of the efficacy and safety of its FDA-approved GammaTile Therapy, and were presented during an Oct.

October 3, 2023 — Using previously taken diagnostic computed tomography (CT) scans in place of CT simulation scans to plan simple palliative radiation treatments can substantially reduce the time some

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now